Shionogi reports 25% jump in Q1 operating profit

Shionogi reported a 24.9% increase in operating profit to 35,097 million yen and a 2.2% rise in revenue to 99,781 million yen for Q1 2026. Profit attributable to owners rose 28.5% to 39,355 million yen.

The company maintained its full-year forecast of 180,000 million yen profit on 530,000 million yen revenue for the fiscal year ending March 2026. Performance was boosted by the strategic acquisition of shares in Torii Pharmaceutical, which became an equity-method affiliate.